Perrigo Co Plc - Company Profile
Powered by
All the data and insights you need on Perrigo Co Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Perrigo Co Plc Strategy Report
- Understand Perrigo Co Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Perrigo Co Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
04 Apr 2022 | Perrigo to Raise USD500 Million in Private Placement of Senior Notes Due 2030 | Debt Offering | - |
Perrigo Co Plc |
25 Mar 2022 | Alliance Pharma Acquires ScarAway and Rights to Sell Kelo-cote from Perrigo | Asset Transaction |
Alliance Pharma Plc
|
Perrigo Co Plc |
25 Nov 2021 | Rosemont Pharma Acquires Oral Liquid Portfolio from Essential Pharma | Asset Transaction |
Rosemont Pharmaceuticals Ltd
|
Essential Pharmaceuticals Ltd
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer